Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

ALLERGAN, INC.
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCalendarCompany 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on ALLERGAN, INC.
2017Mylan defends chairman to ISS ahead of June 22 investor vote
RE
2017ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
PU
2017FEATURED COMPANY NEWS - MYLAN LAUNCH : Generic Reclast® Injection and Generic Az..
AQ
2017U.S. state, local government lawsuits over opioids face uphill battle
RE
2017ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
PU
2017ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
AQ
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
PU
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017HEALTH CANADA APPROVES ALLERGAN PLC : AGN) IBS Drug Viberzi
AQ
More news
Sector news : Pharmaceuticals - NEC
04/23SUSAN KILSBY : Holding(s) In Company
DJ
04/23INVESCO UK LTD INVESCO LTD. : Form 8.3 - Shire Plc
DJ
04/23SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
04/21TAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015MANNKIND : A Head Pain Gain Or A Pocket-Book Drain? 
2015Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update 
2015Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update 
2015Time Warner Is A Buy - Cramer's Lightning Round (5/21/15) 
2015Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update 
Chart ALLERGAN, INC.
Duration : Period :
Allergan, Inc. Technical Analysis Chart | US0184901025 | 4-Traders
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
David Nakasone Investor Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.0
JOHNSON & JOHNSON-9.23%339 783
PFIZER1.13%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY7.07%158 571